Orion Oyj 0M2N.L Stock
Orion Oyj Price Chart
Orion Oyj 0M2N.L Financial and Trading Overview
Orion Oyj stock price | 33.5 EUR |
Previous Close | 41.7 EUR |
Open | 0 EUR |
Bid | 0 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 0 - 0 EUR |
52 Week Range | 0 - 55 EUR |
Volume | 39 EUR |
Avg. Volume | 308 EUR |
Market Cap | 53.06M EUR |
Beta (5Y Monthly) | 0.47931 |
PE Ratio (TTM) | 0.30359763 |
EPS (TTM) | 1.36 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0M2N.L Valuation Measures
Enterprise Value | 6.03B EUR |
Trailing P/E | 0.30359763 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.039361797 |
Price/Book (mrq) | 7.971853 |
Enterprise Value/Revenue | 4.476 |
Enterprise Value/EBITDA | 12.928 |
Trading Information
Orion Oyj Stock Price History
Beta (5Y Monthly) | 0.47931 |
52-Week Change | 8.67% |
S&P500 52-Week Change | 20.43% |
52 Week High | 55 EUR |
52 Week Low | 0 EUR |
50-Day Moving Average | 42.6 EUR |
200-Day Moving Average | 45.75 EUR |
0M2N.L Share Statistics
Avg. Volume (3 month) | 308 EUR |
Avg. Daily Volume (10-Days) | 443 EUR |
Shares Outstanding | 140.7M |
Float | 127.46M |
Short Ratio | N/A |
% Held by Insiders | 32.69% |
% Held by Institutions | 7.04% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.6 |
Trailing Annual Dividend Yield | 3.83% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 24.92% |
Operating Margin (ttm) | 31.37% |
Gross Margin | 62.31% |
EBITDA Margin | 34.62% |
Management Effectiveness
Return on Assets (ttm) | 21.00% |
Return on Equity (ttm) | 49.12% |
Income Statement
Revenue (ttm) | 1.35B EUR |
Revenue Per Share (ttm) | 9.6 EUR |
Quarterly Revenue Growth (yoy) | 2.70% |
Gross Profit (ttm) | 848.9M EUR |
EBITDA | 466.7M EUR |
Net Income Avi to Common (ttm) | 336M EUR |
Diluted EPS (ttm) | 1.362 |
Quarterly Earnings Growth (yoy) | -23.59% |
Balance Sheet
Total Cash (mrq) | 99.8M EUR |
Total Cash Per Share (mrq) | 0.71 EUR |
Total Debt (mrq) | 210.6M EUR |
Total Debt/Equity (mrq) | 28.93 EUR |
Current Ratio (mrq) | 2.634 |
Book Value Per Share (mrq) | 5.187 |
Cash Flow Statement
Operating Cash Flow (ttm) | 405M EUR |
Levered Free Cash Flow (ttm) | -21912500 EUR |
Profile of Orion Oyj
Country | United Kingdom |
State | N/A |
City | Espoo |
Address | Orionintie 1A |
ZIP | 02200 |
Phone | 358 10 4261 |
Website | https://www.orion.fi |
Industry | |
Sector(s) | |
Full Time Employees | 3564 |
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Precedex for intensive care sedative, as well as Fareston for breast cancer. The company also offers Salmeterol/fluticasone Easyhaler; Budesonide/formoterol Easyhaler; Formoterol Easyhaler; Budesonide Easyhaler; Beclomet Easyhaler; and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, it provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic and proprietary drugs, as well as provides contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. The company serves primarily healthcare services providers and professional, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centres, clinics and laboratories. Further, it has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. The company was founded in 1917 and is headquartered in Espoo, Finland.
Q&A For Orion Oyj Stock
What is a current 0M2N.L stock price?
Orion Oyj 0M2N.L stock price today per share is 33.5 EUR.
How to purchase Orion Oyj stock?
You can buy 0M2N.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orion Oyj?
The stock symbol or ticker of Orion Oyj is 0M2N.L.
How many shares does Orion Oyj have in circulation?
The max supply of Orion Oyj shares is 1.28M.
What is Orion Oyj Price to Earnings Ratio (PE Ratio)?
Orion Oyj PE Ratio is 0.24597533 now.
What was Orion Oyj earnings per share over the trailing 12 months (TTM)?
Orion Oyj EPS is 1.36 EUR over the trailing 12 months.